MetLife beats Q4 adjusted EPS expectations

Metlife

04/02/2026 21:25

Overview

Insurance provider's Q4 revenue missed analyst expectations

Adjusted EPS for Q4 beat analyst expectations

Company reported strong volume growth and improved expense margins

Outlook

MetLife did not provide specific future guidance in the press release

Result Drivers

PREMIUM GROWTH - Record sales in pension risk transfers and U.K. longevity reinsurance drove a 29% increase in premiums, fees, and other revenues

INVESTMENT INCOME - Higher variable investment income, particularly from private equity, contributed to a 10% rise in net investment income

EXPENSE MANAGEMENT - Improved expense margins supported a 13% increase in adjusted earnings

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
$23.81 bln
$27.73 bln (7 Analysts)
Q4 Adjusted EPS
Beat
$2.49
$2.34 (15 Analysts)
Q4 EPS
$1.17
Q4 Adjusted Net Income
$1.65 bln
Q4 Net Income
$778 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the life & health insurance peer group is "buy"

Wall Street's median 12-month price target for MetLife Inc is $93.50, about 21.6% above its February 3 closing price of $76.90

The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nBw9ZB55Fa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)